Provided by Tiger Trade Technology Pte. Ltd.

Femasys Inc

2.74
-0.0900-3.18%
Post-market: 2.740.00000.00%16:15 EDT
Volume:35.44K
Turnover:99.28K
Market Cap:22.95M
PE:-0.62
High:2.95
Open:2.90
Low:2.68
Close:2.83
52wk High:22.20
52wk Low:2.02
Shares:8.38M
Float Shares:6.31M
Volume Ratio:0.34
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4145
EPS(LYR):-9.4201
ROE:-424.97%
ROA:-84.22%
PB:5.69
PE(LYR):-0.29

Loading ...

Femasys Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Apr 03

Analysts Are Bullish on These Healthcare Stocks: Femasys (FEMY), Context Therapeutics (CNTX)

TIPRANKS
·
Apr 02

Femasys COO John Charles Canning files initial beneficial ownership statement

Reuters
·
Apr 02

Femasys Names John Canning as New Chief Operating Officer

TIPRANKS
·
Apr 02

Femasys names John Canning chief operating officer to drive commercial growth

Reuters
·
Apr 01

Femasys Q4 EPS $(0.06) Beats $(0.12) Estimate, Sales $813.387K Miss $1.450M Estimate

Benzinga Earnings
·
Apr 01

Femasys 2025 sales jump on FemBloc demand

Reuters
·
Apr 01

Femasys FY25 net loss narrows to $18.6 million; sales rise 40.8% to $2.3 million

Reuters
·
Apr 01

Femasys Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
Apr 01

Press Release: Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update

Dow Jones
·
Apr 01

Femasys announces special stockholder meeting; board recommends voting for proposals 1, 2 and 3

Reuters
·
Mar 28

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 25

Femasys files Form 3 initial beneficial ownership statement for Director Kenneth D. Eichenbaum

Reuters
·
Mar 25

Femasys management to meet virtually with Lake Street

TIPRANKS
·
Mar 24

Femasys Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
Mar 24

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 23

Femasys Amends Financing Terms and Issues New Warrants

TIPRANKS
·
Mar 21

BRIEF-Femasys Enters Omnibus Amendment And Consent Agreement On March 19, 2026 - SEC Filing

Reuters
·
Mar 21

Femasys Inc - Amendment Removes Share Combination Event Adjustment in Notes and Warrants Effective Dec 31, 2025 - SEC Filing

THOMSON REUTERS
·
Mar 21

Femasys issues 16,378,563 unregistered Series D-1 warrants at $0.58 exercise price

Reuters
·
Mar 21